---
layout: work
title: Main Scientific Publication
slug: /publications
---

### **Methodology**
* Mitigating Text Toxicity with Counterfactual Generation [[paper](https://arxiv.org/abs/2405.09948)] <br> Bhan M, Vittaut JN, Achache N, Chesneau N, Blangero A, Legrand V, **Murris J**, Lesot MJ. <br> _3rd World Conference on eXplainable Artificial Intelligence 2025_ (2025)

* Bridging interpretability and survival endpoints in health technology assessment [[preprint](https://hal.science/hal-04967719v1/document)] <br> **Murris J**, Bhan M, Ducrot L, Katsahian S. (2025)
  
* Predicting Hospital Readmission after Cancer Surgery with Survival Analysis and Machine Learning [[short paper](https://zenodo.org/records/13152435)] <br> **Murris J**, Katsahian S, Lavenu A. <br> *International Conference on AI in Healthcare (AIiH), Swansea. AIiH* (2024)

* Random survival forests for the analysis of recurrent events for right-censored data, with or without a terminal event [[preprint](https://hal.science/hal-04612431v1/document)] <br> **Murris J**, Bouaziz O, Jakubczak M, Katsahian S, Lavenu A. (2024)

* A novel methodological framework for the analysis of health trajectories and survival outcomes in heart failure patients [[paper](https://arxiv.org/abs/2403.03138)] <br> **Murris J**, Amadei T, Kirscher T, Klein A, Tropeano AI, Katsahian S. <br> *Learning from Time Series for Health Workshop ICLR 2024* (2024)

* Health technology assessment of artificial intelligence-based medical devices: what healthcare stakeholders need to know on algorithm performance, interpretability and explainability [[paper](https://www.mcpdigitalhealth.org/article/S2949-7612(23)00010-X/fulltext)] <br> Farah L\*, **Murris J**\*, Borget I, Guilloux A, Martelli N, Katsahian S. <br> *Mayo Clinic Proceedings: Digital Health* (2023)

* Towards filling the gap around recurrent events in high dimensional framework: literature review and early comparison [[paper](https://www.tandfonline.com/doi/full/10.1080/24709360.2023.2283650)] <br> **Murris J**, Charles-Nelson A, Tadmouri A, Lavenu A, Katsahian S. <br> *Biostatistics and Epidemiology* (2023)

* A comparison of methods for high-dimensional survival data on small samples: hyperparameter optimization and validation [[short paper](https://jds22.sciencesconf.org/data/pages/LivretJdS22_version_longue.pdf)] <br> Lavenu A, **Murris J**, Mareau A, Rouzé T, Fromont M, Gares V, Katsahian S. <br> *53ème Journées de Statistique de la SFdS* (2022)

### **Clinical studies**
* Evolution of minimally invasive liver surgery in France over the last decade [[paper](https://link.springer.com/article/10.1007/s00464-024-10951-3)] <br> Deyrat J, […] **Murris J**, et al. <br> *Surgical Endoscopy* (2024)
  
* Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people [[paper](https://immunityageing.biomedcentral.com/articles/10.1186/s12979-024-00430-7)] <br> Poisson J, […] **Murris J**, et al. <br> *Immunity & Ageing* (2024)
  
* Protocol for Fever Control Using External Cooling in Mechanically Ventilated Patients with Septic Shock: SEPSISCOOL II Randomised Controlled Trial [[paper](https://bmjopen.bmj.com/content/14/1/e069430.long)] <br> Arnoux A, **Murris J**, et al. <br> *BMJ Open* (2024)

* Risk factors for thromboembolic events in patients hospitalized for Covid-19 pneumonia in general ward and requiring oxygen supply [[paper](https://academic.oup.com/pmj/advance-article-abstract/doi/10.1093/postmj/qgad104/7425479?redirectedFrom=fulltext)] <br> Degrave R, **Murris J**, et al. <br> *Postgraduate Medical Journal* (2023)

* A systematic review and meta-analysis of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis [[paper](https://www.jvsvenous.org/article/S2213-333X(23)00382-7/fulltext#%20)] <br> Espitia O, Raimbeau A, Planquette B, Katsahian S, Sanchez O, Bénichou A, **Murris J**. <br> *Journal of Vascular Surgery: Venous and Lymphatic Disorders* (2023)

* Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and impose poor clinical outcome of patients with lung cancer [[paper](https://www.nature.com/articles/s42003-022-04356-y)] <br> Devi-Marulkar P, […] **Murris J**, et al. <br> *Communications Biology* (2022)

* Adenoma detection rate is enough to assess endoscopist performance: a population-based observational study of FIT positive colonoscopies [[paper](https://pubmed.ncbi.nlm.nih.gov/36118642/)] <br> Denis B, Gendre I, Tuzin N, **Murris J**, Guignard A, Perrin P, Rahmi G. <br> *Endoscopy International Open* (2022)

* Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III study (COLUMBUS) [[paper](https://pubmed.ncbi.nlm.nih.gov/34091420/)] <br> Gogas H, […] **Murris J**, et al. <br> *European Journal of Cancer* (2021)
